Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111575334B reveals a stable immobilized enzyme method for synthesizing chiral alcohols, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN111484400A reveals a green synthesis route for C14 aldehyde, offering cost reduction and high purity for vitamin A acetate manufacturing supply chains.
Patent CN114277006A reveals a novel alcohol dehydrogenase for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant supply chain and cost advantages.
Patent CN114751872B reveals novel Column[5]arene NHC catalyst enabling mild Stetter reactions. Delivers high purity, operational simplicity, and supply chain reliability for global chemical procurement.
Novel Grignard-based route for C11 aldehyde production offers high purity and yield, enabling cost-effective Vitamin A acetate manufacturing.
Patent CN117051052A reveals high-purity NEB-8 synthesis via MrADH. Offers supply chain reliability and significant cost reduction in pharmaceutical intermediate manufacturing processes.
Patent CN117737149A details enzymatic synthesis for high-purity S-vitronectin. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101392225B details a recombinant yeast method for high-purity statin intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN113185443A reveals a green copper-catalyzed route for ketorolac intermediates, offering high purity and significant cost reduction in API manufacturing.
Patent CN101962661B reveals high-efficiency carbonyl reductase for statin intermediates. Offers superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Advanced solid-phase synthesis of liraglutide intermediates using microwave technology. Delivers high purity, reduced costs, and reliable supply chain solutions.
Patent CN113200932B reveals a novel TDAC-catalyzed route for oxazolidinone synthesis, offering metal-free purity and chiral retention for pharmaceutical intermediates.
Novel synthesis route for 2,3-diamino-4-bromopyridine offers high yield and cost efficiency for kinase inhibitor manufacturing supply chains and global procurement.
Patent CN103408459B details a high-yield route for 4-cyanophenylalanine. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel patent CN108912030A offers high-purity Imrecoxib synthesis with reduced cost and scalable supply chain reliability for pharmaceutical manufacturing.
Patent CN102675168A details a high-ee iridium-catalyzed allylation method for chiral thioethers, offering superior regioselectivity and mild conditions for API intermediates.
Novel desulfurization addition method using aryl sulfonyl hydrazides offers mild conditions and broad substrate tolerance for reliable aromatic ketone manufacturing.
Patent CN117285537B reveals high-purity Upatinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103880776A reveals a novel solid-phase grinding method for 2-amino-5-alkyl-1,3,4-thiadiazoles, offering high yields and simplified processing for pharmaceutical intermediates.
Patent CN109384659B reveals a green synthesis route for Vitamin K3 using phthalic diesters, eliminating heavy metal waste and offering significant cost reduction in pharmaceutical intermediate manufacturing.